Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sialate:O-sulfotransferase 2 (WSCD2) is a protein-coding enzyme located on human chromosome 12. It catalyzes the transfer of a sulfate group to the 8-O position of sialic acid residues within glycoproteins, prominently including transferrin. The enzyme uses 3'-phosphoadenosine 5'-phosphosulfate (PAPS) as a sulfate donor, resulting in formation of 8-O-sulfated Sia-glycans. WSCD2’s main molecular classification is as a sulfotransferase, and it is predicted to operate in the Golgi membrane. Although cataloged as associated with certain skin diseases and personality trait loci, there is no established role for WSCD2 as a therapeutic target, nor are there known drugs or safety concerns linked to this molecule as of 2025.
If a drug were to target WSCD2, plausible mechanisms would be enzyme inhibition or modulation of glycan sulfation, but no drugs have been described with such mechanisms for this molecule. Actions would be expected to alter the level or pattern of 8-O-sulfated sialic acid glycans.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sialate:O-sulfotransferase 2 (WSCD2).